Tango Therapeutics, Inc. (NASDAQ: TNGX), a clinical-stage biotechnology company committed to delivering breakthrough targeted therapies that extend and improve the lives of patients with cancer and ...

Nvidia's Q3 FY2027 preview: $108 billion revenue guide, 74% margin target, and $279 billion in supply commitments testing its ...

A retrospective cohort study of 171 patients found that ultrasound-guided trigeminal nerve block was associated with fewer ...

If the Texas Rangers and Jacob deGrom agree to part ways this offseason, the two-time Cy Young winner should have a wide ...

The Morning Bull - US Market Morning Update Monday, Nov, 2 2026 US stocks are set for a cautiously positive open, with index ...

NVIDIA remains a structural margin leader, maintaining a Buy rating with a $255 base case target despite increased balance ...

Krystal Biotech delivered a clean commercial beat in the third quarter. It earned $2.05 per share on revenue of $127.34 million, topping the $1.84 consensus by 11.4% and the $124.65 million revenue ...

AI in myeloproliferative neoplasms can grade marrow fibrosis and predict survival, but authors say prospective, ...

"I'll just check the box for AI agents on the existing OAuth client and be done with it."When you open the Google Cloud ...

Discover the top 10 breast cancer studies to watch at SABCS 2026, including major ADC, immunotherapy, surgery omission, and ...

A retrospective study of 578 patients found that adding rapid biopsy-side-down positioning to thrombin tract injection was ...

Nvidia disclosed $279B in long-term supply/capacity commitments, doubling from Q2 and sixfold year-over-year, as demand ...